Results 241 to 250 of about 279,027 (307)

Bioequivalence : prerequisite for generic drugs [PDF]

open access: yes, 2014
Muriel Masanes, Mireia   +1 more
core  

Low‐dose cannabidiol increases plasma concentrations of amitriptyline: A clinical drug–drug interaction study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Cannabidiol (CBD), the main non‐intoxicating compound from the cannabis plant, is regularly used by patients with chronic pain who also take analgesics. CBD has previously been shown to inhibit CYP‐mediated drug metabolism. This study aimed to characterize the potential pharmacokinetic interaction of CBD with amitriptyline and tramadol ...
Andriy A. Gorbenko   +9 more
wiley   +1 more source

Prescribing Trends of Antihypertensive Medications: An Observational Study in a Tertiary Care Hospital in India. [PDF]

open access: yesCureus
Suneja K   +9 more
europepmc   +1 more source

Clinical and radiological outcomes of directed treatment transitions from Gilenya<sup>®</sup> to generic fingolimod. [PDF]

open access: yesMult Scler
Patel MA   +13 more
europepmc   +1 more source

Prices, availability, and affordability of selected medicines for asthma management in Nigeria: a nationwide study. [PDF]

open access: yesBMC Health Serv Res
Amorha KC   +23 more
europepmc   +1 more source

Perception of Generic Drugs Among Pharmacists in Poland: The Role of Sociodemographic Factors in Shaping Professional Attitudes and Practices. [PDF]

open access: yesHealthcare (Basel)
Lewandowski M   +9 more
europepmc   +1 more source

Manufacturing Supply Chains and Imports in the ADHD Drug Shortage.

open access: yesJAMA Health Forum
Currie J, Malinovskaya A.
europepmc   +1 more source

Toward the harmonization of bioequivalence guidelines in Europe: Commentary on the state of the art and future priorities under ICH M13A for immediate‐release oral forms

open access: yes
British Journal of Clinical Pharmacology, EarlyView.
Domenico Nocera   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy